LSE : 0QLN.L

Tecan Group AG

$178.93022 CHF

$0.85 (0.48%)

Volume
2.07K
Average Volume
7.88K
Market Capitalization
$2.24B
P/E Ratio
-20.54
Dividend Yield
1.67%
Price Target
Year High
$412.60
Year Low
$175.30
Day High
—
Day Low
—
Payout Ratio
-$0.34
Current Ratio
$2.46
Company Overview

LSE

Monica Manotas

Medical - Diagnostics & Research

Healthcare

0QLN.L

3074

CH

CHF

https://www.tecan.com

41 44 922 88 88

N/A

N/A

Liquidity Metrics

0.19

2.46

1.73

0.61

-0.34

Sales & Valuation

$882.48M

2.57

1.97

22.13

8.10

Profitability

-$8.74

-$110.65M

-12.54%

-11.47%

-9.09%

-6.52%

P/E Metrics

-20.54

0.08

0.08

Analyst Price Target & Rating

Sell

2/5

0 Analysts

%

Financial Health Scores

4.34

4/9

$422.99M

$1.8B

$638.99M

$102.81M

Key Metrics (TTM)

No key metrics data available.

Company Executives
Name Title
Carsten Boegh Chief Technology Officer, Executive Vice President, Head Research & Development & Member of the Management Board
Erik Norström Head of Corporate Development, Executive Vice President & Member of Management Board
Martin Brandle Senior Vice President of Corporate Communications & Investor Relations
Ingrid Purgstaller Chief People Officer & Member of the Management Board
Mukta Acharya EVP, Head of the Life Sciences Business Division & Member of the Management Board
Wolfgang Deuringer President of Sales International
Camila Japur Chief Financial Officer
Tania Micki Chief Financial Officer & Member of Management Board
Monica Manotas Chief Executive Officer, Interim Head of the Partnering Business division & Member of Management Board
Sarah Vowles Director Sustainability & Corporate Communications
Ulrich Kanter Executive Vice President, Global Head of Operations & IT and Member of Management Board
Andreas Wilhelm EVice President of Legal, Qua. & Regu. Affairs, Gen. Cou., Sec. of the Board of Dir. & Mem. of Mgmt Board
Poll Results

No votes yet today — be the first to share your view!

About Tecan Group AG (LSE:0QLN.L) Stock

Tecan Group AG, established in 1980 and based in Männedorf, Switzerland, provides advanced laboratory instruments and comprehensive solutions. The company caters to a wide range of clients globally, including pharmaceutical and biotechnology companies, academic research institutions, and forensic and diagnostic laboratories. Its operations are divided into two primary segments: Life Sciences Business and Partnering Business. The company's product portfolio is extensive, featuring automated liquid handling and robotic systems, microplate readers and washers, essential consumables, next-generation sequencing (NGS) reagents, immunoassays, and specialized software. Noteworthy proprietary solutions include Tecan Laberwax, an automation platform, and Resolvex, designed for intelligent sample pre ... paration in diverse fields such as genomics, synthetic biology, drug discovery, analytical chemistry, cell biology, and ELISA applications. Furthermore, Tecan develops and manufactures critical components like precision pumps, valves, and robotic arms, alongside developer software, for other laboratory instrument manufacturers serving life science research, diagnostics, and various industrial sectors. Key instrument lines include Synergence, Freedom EVO, and Fluent. Tecan Group AG has a significant international presence, conducting business throughout Switzerland, other European countries, North America, and Asia.

Frequently Asked Questions

What is the current Tecan Group AG (0QLN.L) stock price?

Tecan Group AG(LSE:0QLN.L) stock price is $178.93022 in the last trading session. During the trading session, 0QLN.L stock reached the peak price of $412.6 while $175.3 was the lowest point it dropped to. The percentage change in 0QLN.L stock occurred in the recent session was 0.48% while the dollar amount for the price change in 0QLN.L stock was $0.85.

0QLN.L's industry and sector of operation?

The LSE listed 0QLN.L is part of Medical - Diagnostics & Research industry that operates in the broader Healthcare sector.

Who are the executives of 0QLN.L?

Carsten Boegh | Chief Technology Officer, Executive Vice President, Head Research & Development & Member of the Management Board
Erik Norström | Head of Corporate Development, Executive Vice President & Member of Management Board
Martin Brandle | Senior Vice President of Corporate Communications & Investor Relations
Ingrid Purgstaller | Chief People Officer & Member of the Management Board
Mukta Acharya | EVP, Head of the Life Sciences Business Division & Member of the Management Board

How many employees does 0QLN.L have?

Number of 0QLN.L employees currently stands at 3074. 0QLN.L operates from Seestrasse 103, Männedorf, ZH 8708, CH.

Link for 0QLN.L official website?

Official Website of 0QLN.L is: https://www.tecan.com

How do I contact 0QLN.L?

0QLN.L could be contacted at phone #41 44 922 88 88 and can also be accessed through its website. 0QLN.L operates from Seestrasse 103, Männedorf, ZH 8708, CH.

How many shares of 0QLN.L are traded daily?

The average number of 0QLN.L shares traded daily for last 3 months was 7.88K.

What is the market cap of 0QLN.L currently?

The market value of 0QLN.L currently stands at $2.24B with its latest stock price at $178.93022